from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1301/-

LFCtreatmentdescriptionclass of inhibitor

-0.758

Amikacinug/mL Amikacintranslation

-1.741

Cap5-10ug/mL Capreomycintranslation

-2.498

Rox10-50 ug/mL Roxithromycintranslation

0.421

SM2-5 ug/mL Streptomycintranslation

-1.613

Tet5-10 ug/mL Tetracyclinetranslation

-0.903

Rif0.2-5ug/mL Rifampicintranscription

0.373

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.858

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.014

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.361

CPZ10-50 ug/mL Chlorpromazinerespiration

0.931

Clofazimine10-13 ug/mL Clofaziminerespiration

0.343

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.856

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.128

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.868

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.073

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.195

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.488

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.769

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.349

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.458

KCN5-20 ug/mL Potassium cyaniderespiration

-0.140

NaN30.2-2 mM Sodium aziderespiration

-0.707

Nigericin50 uM Nigericinrespiration

0.277

TRC10-150 ug/mL Triclosanrespiration

-0.047

TRZ10-25 ug/mL Thioridazinerespiration

0.420

Valinomycin0.5-10 uM Valinomycinrespiration

-0.475

ZnSO42 mM ZnSO4respiration

0.333

menadione6-10 ug/mL Menadionerespiration

0.033

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.472

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.279

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.906

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.106

NRP_1Non-replicating persistence stage 1dosRassociated

-0.254

Amp0.2mg/mL AmpicillincellWall

-0.533

Cephalexin20-100 ug/mL CephalexincellWall

-0.380

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.351

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.150

EMB10-20 ug/mL EthambutolcellWall

0.073

Eta12-40 ug/mL EthionamidecellWall

0.202

INH0.2-0.4 ug/mL IsoniazidcellWall

0.034

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.742

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.823

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.154

BZA0.12 mg/mL BenzamidearomaticAmides

-0.181

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.342

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.231

H2O24 mM hydrogen peroxideDNAdamaging

0.489

Levo10 ug/mL LevofloxacinDNAdamaging

-0.180

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

3.205

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.395

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.238

UVUV-irradiationDNAdamaging

1.133

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.421

Antimycin12.5-50 ug/mL Antimycin A?

-0.684

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.154

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.459

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.801

PA8240.2-2 ug/mL PA-824?

1.714

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.012

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.176

Verapamil50 uM Verapamil?

0.297

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.121

methoxatin10-20 ug/mL Methoxatin?